EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A Single Institution Experience With Immediate Lymphatic Reconstruction: Impact of Insurance Coverage on Risk Reduction

Anne Huang, Emma Koesters, Rebecca M Garza, Summer E Hanson, David W Chang

Journal of Surgical Oncology · 2025

DOI: 10.1002/jso.28067 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2025. Verfasst von Anne Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Section of Plastic and Reconstructive Surgery, University of Chicago Medicine & Biological Sciences, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Insurance Coverage, Lymphedema, Insurance, Health. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives Immediate lymphatic reconstruction (ILR) performed to prevent breast cancer related lymphedema is not consistently covered by insurance payors in the United States.

Methods

Retrospective review was performed on a prospective database of ILR candidates from 2018 to 2022. Candidates were identified as patients with clinical axillary lymph node involvement at the time of breast cancer diagnosis. Patient demographics, insurance type, and development of lymphedema were recorded.

Results

One hundred and eighty ILR candidates were identified, 50 of whom underwent ILR. Non‐ILR patients were more likely to be of black race, have Medicaid health insurance, earn lower median household income, and have lower rates of out‐of‐pocket payment when not covered by insurance. In 40 cases where ILR was indicated but not performed, 55% were due to financial reasons. After a minimum of 1 year follow up, 14.6% (6/41) of patients who underwent ILR had lymphedema, compared with 12.5% (9/72) of patients who had no clinical indication for ILR and 40% (10/25) of patients who did not undergo ILR when clinically indicated ( p = 0.012).

Conclusions

Disparities in insurance coverage and financial resources may adversely impact access and outcomes in patients clinically indicated for ILR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsInsurance CoverageLymphedemaInsurance, HealthPlastic Surgery ProceduresHumansFemaleRetrospective StudiesMiddle AgedUnited StatesAgedAdultFollow-Up Studies

Stichwörter der Autor:innen

LYMPHAbreast cancer related lymphedemaimmediate lymphatic reconstructionlymphovenous bypass

Autor:innen und Institutionen

  • Section of Plastic and Reconstructive Surgery, University of Chicago Medicine & Biological Sciences, Chicago, Illinois, USA.
  • Rebecca Garza Plastic Surgery, Schererville, Indiana, USA.

Zitieren

APA

Huang, A., Koesters, E., Garza, R. M., Hanson, S. E., & Chang, D. W. (2025). A Single Institution Experience With Immediate Lymphatic Reconstruction: Impact of Insurance Coverage on Risk Reduction. Journal of Surgical Oncology. https://doi.org/10.1002/jso.28067

Vancouver

Huang A, Koesters E, Garza RM, Hanson SE, Chang DW. A Single Institution Experience With Immediate Lymphatic Reconstruction: Impact of Insurance Coverage on Risk Reduction. Journal of Surgical Oncology. 2025. doi:10.1002/jso.28067

BibTeX
@article{Huang2025,
  author = {Huang, Anne and Koesters, Emma and Garza, Rebecca M and Hanson, Summer E and Chang, David W},
  title = {A Single Institution Experience With Immediate Lymphatic Reconstruction: Impact of Insurance Coverage on Risk Reduction},
  journal = {Journal of Surgical Oncology},
  year = {2025},
  doi = {10.1002/jso.28067}
}
Kostenlos starten →